Pharmaceutical Executive September 10, 2024
AI is a tool to make drug discovery cheaper, faster, and better — not a replacement for human ingenuity.
The AI revolution is shaping numerous facets of our lives. While advancements by OpenAI and Anthropic plus NVIDIA’s market performance have commanded a significant portion of media attention, the overall impact of advanced computational methods in biopharma has been largely underreported. On the front lines of drug development, a combination of AI with computational modelling and bioinformatics has become fundamental for the advancement of drug development research we’ve seen over the last decade.
Drug discovery has historically been a long, inefficient and protracted process, heavily reliant on serendipity, often tedious persistence and, good ole’-fashioned trial and error. This meant time. Lots...